Contraception
Volume 77, Issue 1 , Pages 6-9 , January 2008

Intrauterine contraception as an alternative to interval tubal sterilization

  • David A. Grimes

      Affiliations

    • Family Health International, P. O. Box 13950, Research Triangle Park, NC 27709, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 544 7040; fax: +1 919 544 7261.
    • ,
  • Daniel R. Mishell Jr.

      Affiliations

    • The Keck School of Medicine, University of Southern California, Los Angeles CA 90033, USA

Received 15 June 2007 ,Revised 12 September 2007 ,Accepted 12 September 2007.

References 

  1. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception. 2007;75:S161–S166
  2. Mansour D. Copper IUD and LNG IUS compared with tubal occlusion. Contraception. 2007;75:S144–S151
  3. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat, Series 23. 2005;25:1–160
  4. Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195:1272–1277
  5. Van Ee R, Hemrika DJ, De Blok S, Van Der Linden C, Lip H. Effects of ketoprofen and mesosalpinx infiltration on postoperative pain after laparoscopic sterilization. Obstet Gynecol. 1996;88:568–572
  6. Benhamou D, Narchi P, Mazoit JX, Fernandez H. Postoperative pain after local anesthetics for laparoscopic sterilization. Obstet Gynecol. 1994;84:877–880
  7. Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol. 1996;174:1161–1168[discussion 1168–70]
  8. World Health Organization . Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56:341–352
  9. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception. 2007;75:S70–S75
  10. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception. 1994;49:56–72
  11. Sivin I, el Mahgoub S, McCarthy T, et al. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception. 1990;42:361–378
  12. Jamieson DJ, Kaufman SC, Costello C, Hillis SD, Marchbanks PA, Peterson HB. A comparison of women's regret after vasectomy versus tubal sterilization. Obstet Gynecol. 2002;99:1073–1079
  13. Schmidt JE, Hillis SD, Marchbanks PA, Jeng G, Peterson HB. Requesting information about and obtaining reversal after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Fertil Steril. 2000;74:892–898
  14. Skjeldestad FE. Conception rates post IUD removal. In:  Bardin CW,  Mishell DR editor. Proceedings from the Fourth International Conference on IUDs. Boston: Butterworth-Heinemann; 1994;p. 63–75
  15. Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study. Am J Obstet Gynecol. 1989;160:391–396
  16. Belhadj H, Sivin I, Diaz S, et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception. 1986;34:261–267
  17. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception. 1992;46:575–584
  18. Van Voorhis BJ. Comparison of tubal ligation reversal procedures. Clin Obstet Gynecol. 2000;43:641–649
  19. Trussell J, Guilbert E, Hedley A. Sterilization failure, sterilization reversal, and pregnancy after sterilization reversal in Quebec. Obstet Gynecol. 2003;101:677–684
  20. Witsenburg C, Dieben S, Van der Westerlaken L, Verburg H, Naaktgeboren N. Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril. 2005;84:99–107
  21. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet. 2000;356:1013–1019
  22. Jamieson DJ, Hillis SD, Duerr A, Marchbanks PA, Costello C, Peterson HB. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of sterilization. Obstet Gynecol. 2000;96:997–1002
  23. Escobedo LG, Peterson HB, Grubb GS, Franks AL. Case-fatality rates for tubal sterilization in U.S. hospitals, 1979 to 1980. Am J Obstet Gynecol. 1989;160:147–150
  24. Franks AL, Beral V, Cates W, Hogue CJ. Contraception and ectopic pregnancy risk. Am J Obstet Gynecol. 1990;163:1120–1123
  25. Curtis KM, Marchbanks PA, Peterson HB. Neoplasia with use of intrauterine devices. Contraception. 2007;75:S60–S69
  26. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA. 1993;270:2813–2818
  27. Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65,000 sterilized women. Int J Epidemiol. 2004;33:596–602
  28. Green A, Purdie D, Bain C, et al. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer. Survey of Women's Health Study Group. Int J Cancer. 1997;71:948–951
  29. Narod SA, Sun P, Ghadirian P, et al. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet. 2001;357:1467–1470
  30. Chiou CF, Trussell J, Reyes E, et al. Economic analysis of contraceptives for women. Contraception. 2003;68:3–10
  31. Steiner MJ, Trussell J, Mehta N, Condon S, Subramaniam S, Bourne D. Communicating contraceptive effectiveness: a randomized controlled trial to inform a World Health Organization family planning handbook. Am J Obstet Gynecol. 2006;195:85–91
  32. Varma R, Sinha D, Gupta JK. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) — a systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol. 2006;125:9–28
  33. Curtis KM, Mohllajee AP, Peterson HB. Regret following female sterilization at a young age: a systematic review. Contraception. 2006;73:205–210
  34. Skjeldestad F, Bratt H. Fertility after complicated and non-complicated use of IUDs. A controlled prospective study. Adv Contracept. 1988;4:179–184
  35. Walsh T, Grimes D, Frezieres R, Nelson A, Bernstein L, Coulson A, et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet. 1998;351:1005–1008

PII: S0010-7824(07)00428-3

doi: 10.1016/j.contraception.2007.09.012

Contraception
Volume 77, Issue 1 , Pages 6-9 , January 2008

Article Tools

* Image Usage & Resolution